Helsinn's Swiss manufacturing subsidiary bags 2015 CMO Leadership Award

Helsinn manufacturing achieved a top 10% score in eight buyer perception categories

Helsinn, the Swiss Group focused on building quality cancer care, is pleased to announce that its Swiss manufacturing subsidiary, Helsinn Advanced Synthesis SA, has won a 2015 CMO Leadership Award, determined by contract manufacturing client research.

The CMO Leadership Awards are organized annually by Life Science Leader magazine (http://www.lifescienceleader.com/) and are designed to recognize leading contract manufacturing organizations that achieve a top 10 percentile score in one or more of the following categories: Innovation, Productivity, Quality, Regulatory, and Reliability. The research is initiated by marketing provider That's Nice LLC through a comprehensive survey tool individually targeting big pharma, mid-sized & specialty pharma, emerging pharma, biotech, and emerging biotech.

Helsinn won an award, achieving top 10 percentile scores in several client outsourcing categories, and earned a place among the best in the industry. The CMO Leadership Awards were presented on 18 March 2015, at the W Hotel, Lexington Avenue, New York.

"Helsinn is honored to have received the award for:

• Quality

• Reliability

• Productivity

• Regulatory

• Innovation

We believe this is a reflection of our continued efforts in quality management and our ability to deliver high quality products and services together with our partners throughout our 30 year history in pharmaceutical bulk drug manufacturing," said Dr Waldo Mossi, Helsinn Advanced Synthesis' General Manager.

SOURCE Helsinn Group